Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Weak
Garp
Strong
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Weak
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Website
Eton Pharmaceuticals, Inc.
Telephone
1.847.787.7361
Address
Suite 235, 21925 West Field Parkway, Deer Park, IL 60010-7278
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 13.09 - 33.41
Trade Value (12mth)
US$1,684,507.00
1 week
8.69%
1 month
39.72%
YTD
102.28%
1 year
62.5%
All time high
33.41
EPS 3 yr Growth
-52.30%
EBITDA Margin
5.10%
Operating Cashflow
$11m
Free Cash Flow Return
20.50%
ROIC
-9.00%
Interest Coverage
0.90
Quick Ratio
1.20
Shares Outstanding (Fully Diluted)
32m
HALO Sector
Healthcare
Next Company Report Date
18-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 20 May 26 | |
| 20 May 26 | |
| 15 May 26 | |
| 15 May 26 | |
| 15 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.04 | -0.15 | -0.17 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.04 | -0.15 | -0.17 | | | | ||
Growth | % | | | | | 89.8 | -304.4 | -15.9 | | | | ||
PE | X | | | | | 448 | 700 | 56.1 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | 111.7 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
